T. Parasuraman

发表

Single-Dose Ondansetron Prevents Postoperative Vomiting in Pediatric Outpatients

F. McGowan, L. Ferrari, P. Davis, 1997, Anesthesia and analgesia.

Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life.

R. Aparasu, T. Parasuraman, R. McCoy, 1999, Journal of pain and symptom management.

A Comparison of the Efficacy, Safety, and Patient Satisfaction of Ondansetron Versus Droperidol as Antiemetics for Elective Outpatient Surgical Procedures

P. Glass, T. Gan, C. Moote, 1998, Anesthesia and analgesia.

Single-Dose Ondansetron Prevents Postoperative Vomiting in Pediatric Outpatients

F. McGowan, L. Ferrari, R. Hannallah, 1997, Anesthesia and analgesia.

Economic Impact with Home Delivery of Chemotherapy to Pediatric Oncology Patients

M. Holdsworth, D. Raisch, F. Cox, 1997, The Annals of pharmacotherapy.

A53 Patient Satisfaction and Pharmacoeconomic Comparison of Ondasetron vs. Droperidol for the Prevention of Postoperative Nausea and Vomiting in Ambulatory Surgical Patients

P. Glass, T. Gan, J. Fortney, 1997 .

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.

S. Madajewicz, W. Tester, T. Grote, 1996, Clinical therapeutics.

Ondansetron Compared with Granisetron in the Prophylaxis of Cyclophosphamide-lnduced Emesis in Out-Patients: A Multicentre, Double-Blind, Double-Dummy, Randomised, Parallel-Group Study

J. Forster, L. Goedhals, X. Froger, 1995 .

Efficacy and tolerability of oral ondansetron versus prochlorperazine in the prevention of emesis associated with cyclophosphamide-based chemotherapy and maintenance of health-related quality of life.

S. Madajewicz, W. Tester, T. Grote, 1996, Clinical therapeutics.